Richmond Minerals Inc (RMD) Fair Value & Analysis
Healthcare · CA · Market cap A$40.1B
Fair value as of: Jun 24, 2026
From 24 valuation models · updated 5 days ago
Fair value updated Jun 24, 2026 — revised from A$20.87 to A$18.79 (−10.0%) since Jun 23, 2026. Share price −1.4% over the past month.
Price vs Fair Value (12 months)
12‑month range A$24.14 – A$41.87 · fair‑value band A$14.15 – A$27.13 · the A$27.04 price screens above the A$18.79 fair value. As of Jun 24, 2026.
✦ Which stocks are undervalued right now? Check free Discover now →Analysis
Richmond Minerals Inc (RMD) currently trades at A$27.04, while our model-based Fair Value estimate is A$18.79 — implying the stock looks roughly 30.5% overvalued today. We read business quality at 95/100 (high quality), in the Healthcare sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: high).
Over the trailing twelve months, Richmond Minerals Inc generated revenue of A$5.5B at a net margin of 27.4%. Revenue grew 10.8% year over year. It earns a return on equity of 25.3%. The balance sheet holds a net cash position of A$358M. Fundamentals as of Jun 24, 2026
Key figures & financial health
More key figures
Figures from reported company fundamentals (EODHD) · as of Jun 24, 2026. TTM = trailing twelve months.
About the company
Richmond Minerals Inc. engages in the exploration, development, and evaluation of base and precious metals in Canada. It holds 100% interest in Ridley Lake Gold property which consists of 196 contiguous unpatented mineral claims located in the Swayze Area, Porcupine Mining Division, Raney and Rollo Townships, Ontario. The company was formerly known as Aavdex Corp. and changed its name to Richmond Minerals Inc. in November 2005. Richmond Minerals Inc. was founded in 1983 and is headquartered in Toronto, Canada.
Revenue & earnings trend
FY2021 – FY2025 · reported fiscal years
Richmond Minerals Inc reported revenue of A$5.1B in FY2025 versus A$3.2B in FY2021, a compound +12.6%/yr. Reported net income was A$1.4B in FY2025, compounding +31.1%/yr from FY2021.
Open the full interactive analysis →
Similar stocks
6 more Medical Instruments & Supplies stocks, each showing price versus our Fair Value estimate (as of Jun 24, 2026).
| Stock | Price | Fair Value | vs Fair Value |
|---|---|---|---|
| Intuitive Surgical, Inc ISRG | $412.02 | $165.35 | -60% |
| EssilorLuxottica Société anonyme ESLOF | $190.25 | $125.65 | -34% |
| HOYA Corporation HOCPY | $168.16 | $96.16 | -43% |
| Medline Inc MDLN | $36.54 | $30.66 | -16% |
| Becton, Dickinson and Company BDX | $140.71 | $104.17 | -26% |
| Alcon Inc ALC | $65.18 | $44.21 | -32% |
Explore undervalued stocks
More undervalued Healthcare stocks →
Frequently asked questions
Is Richmond Minerals Inc (RMD) undervalued?
What is the fair value of RMD?
What is the quality score of RMD?
What is the revenue of Richmond Minerals Inc (RMD)?
What is the net profit margin of RMD?
Does Richmond Minerals Inc pay a dividend?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.
Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.